Jump Financial’s Bio-Rad Laboratories Class A BIO Stock Holding History

Jump Financial’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-10,337	Closed	-$3.46M	–	1656
2024 Q3	$3.46M	Buy	10,337 +1,058	+11%	+$336K	0.07%	326
2024 Q2	$2.53M	Buy	+9,279	New	+$2.7M	0.05%	458
2024 Q1	–	Sell	-5,163	Closed	-$1.67M	–	1905
2023 Q4	$1.67M	Buy	+5,163	New	+$1.62M	0.05%	464
2023 Q3	–	Sell	-7,516	Closed	-$2.85M	–	1863
2023 Q2	$2.85M	Buy	+7,516	New	+$3.06M	0.11%	261
2023 Q1	–	Sell	-12,424	Closed	-$5.22M	–	1598
2022 Q4	$5.22M	Buy	12,424 +1,966	+19%	+$794K	0.27%	92
2022 Q3	$4.36M	Buy	10,458 +10,051	+2,470%	+$5.01M	0.17%	175
2022 Q2	$202K	Buy	+407	New	+$212K	0.01%	1310
2022 Q1	–	Sell	-735	Closed	-$555K	–	1555
2021 Q4	$555K	Buy	+735	New	+$550K	0.03%	605

Other funds holding BIO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VAM

Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Jump Financial's BIO Position: Q4 2024 in Review

Jump Financial sold out of Bio-Rad Laboratories Class A (BIO) in Q4 2024, closing a stake of 10,337 shares — an estimated $3.46M sold.

Jump Financial first reported a position in BIO in Q4 2021 and held it in 8 quarters. The position peaked at $5.22M in Q4 2022. 457 funds tracked by Wall St. Rank hold BIO as of Q4 2024.

Jump Financial reported no remaining Bio-Rad Laboratories Class A position as of Q4 2024 after selling out during the quarter.
Jump Financial sold 10,337 Bio-Rad Laboratories Class A shares in Q4 2024, an estimated $3.46M.
Jump Financial first reported a position in Bio-Rad Laboratories Class A in Q4 2021 and held it in 8 quarters.
Jump Financial's Bio-Rad Laboratories Class A position peaked at $5.22M in Q4 2022.
457 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2024.

Based on Jump Financial's 13F filing for Q4 2024, filed 13 Feb 2025.